Pharmacokinetic/Pharmacodynamic (PK/PD) Evaluation of Dalbavancin Alone and in Combination with Ceftaroline against Methicillin-Resistant Strains (MRSA) of Staphylococcus aureus

Παρόμοια τεκμήρια

• Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a Simulated Pharmacodynamic/Pharmacokinetic Model
  ανά: Kebriaei, Razieh, κ.ά.
  Έκδοση: (2019)
• Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model
  ανά: Abdul-Mutakabbir, Jacinda C., κ.ά.
  Έκδοση: (2020)
• Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model
  ανά: Barber, Katie E., κ.ά.
  Έκδοση: (2015)
• 1321. Population Pharmacokinetic (PK) and Pharmacokinetic/Pharmacodynamic (PK/PD) Target Attainment Analyses for Dalbavancin in Pediatric Patients
  ανά: Carrothers, Timothy J, κ.ά.
  Έκδοση: (2020)
• Dalbavancin reduces biofilms of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE)
  ανά: Knafl, D., κ.ά.
  Έκδοση: (2016)